新冠疫情前后英格兰自身免疫性风湿病诊断趋势:基于OpenSAFELY的人群队列研究
该研究利用英格兰全人群初级保健与住院数据,评估十种自身免疫性风湿病在2016至2025年间的发病诊断率。疫情第一年除小血管炎外诊断率均急剧下降;截至2025年3月,银屑病关节炎、类风湿关节炎和巨细胞动脉炎诊断数仍低于预期,而中轴脊柱关节炎诊断数高于疫情前水平,且2023年起女性诊断率超过男性。
要点
- 疫情后银屑病关节炎、类风湿关节炎和巨细胞动脉炎诊断数持续低于预期。
- 中轴脊柱关节炎诊断数高于疫情前水平,2023年起女性诊断率超过男性。
- 结缔组织病早期诊断不足后出现补偿性增加。
核心结论
- 疫情开始5年后,银屑病关节炎、类风湿关节炎和巨细胞动脉炎的诊断数仍持续减少,而中轴脊柱关节炎诊断数增加,尤其在女性中。
- 数据驱动的疾病监测可用于识别这些变化的驱动因素并应对延迟诊断的长期影响。
研究设计与样本
- 基于OpenSAFELY平台的人群水平观察性队列研究,经NHS England批准,使用英格兰所有在TPP健康记录软件注册的成人(≥18岁)初级保健和住院数据。
- 评估2016年4月1日至2025年3月31日期间十种自身免疫性风湿病的发病诊断率,使用Prophet时间序列预测建模疫情后预期诊断率并与观察值比较。
主要发现
- 疫情第一年,除小血管炎外所有自身免疫性风湿病诊断率均急剧下降。
临床怎么用
- 临床应关注银屑病关节炎、类风湿关节炎和巨细胞动脉炎可能存在的诊断延迟,并警惕中轴脊柱关节炎诊断增加的趋势。
- 可利用数据驱动的疾病监测识别诊断率变化的驱动因素,并应对延迟诊断的长期影响。
局限性
- 本研究为观察性设计,可能受数据记录完整性及疫情期就医行为变化影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During the first year of the COVID-19 pandemic, diagnosis rates were reported to have declined for several autoimmune rheumatic diseases in numerous countries. It remains unclear whether diagnosis rates have since returned to pre-pandemic levels. This study aimed to evaluate diagnosis rates across autoimmune rheumatic diseases in the pre-pandemic and post-pandemic periods, with comparisons by disease, age group, sex, ethnicity, and socioeconomic status. METHODS: With NHS England approval, this population-level, observational cohort study used primary care and hospital admission data from all adults (aged ≥18 years) in England registered with general practices using TPP health record software, via the OpenSAFELY platform. Incident diagnosis rates for ten autoimmune rheumatic diseases were evaluated between April 1, 2016, and March 31, 2025. Expected diagnosis rates after pandemic onset (March, 2020) were modelled using Prophet time-series forecasting and compared with observed rates. FINDINGS: 23 353 040 adults had data available for analysis and were included in the reference population. Mean age was 46·2 years (SD 18·8). 11 776 490 (50·4%) of 23 353 040 individuals were female and 11 576 545 (49·6%) were male; 18 581 585 (79·6%) were White, 1 923 140 (8·2%) were Asian or Asian British, 700 025 (3·0%) were Black or Black British, 332 490 (1·4%) were mixed ethnicity, 691 475 (3·0%) were Chinese or other ethnicity, and 1 124 325 (4·8%) had unknown ethnicity. In the first year of the pandemic, diagnosis rates sharply declined across all autoimmune rheumatic diseases except for small vessel vasculitis. As of March, 2025, cumulative reductions in diagnoses remained for psoriatic arthritis (-12 320 diagnoses, 95% prediction interval [PI] -12 780 to -11 860; percentage difference -24·9%, 95% PI -25·6 to -24·2), rheumatoid arthritis (-11 690 diagnoses, -13 280 to -10 110; -9·8%, -11·0 to -8·6), and giant cell arteritis (-5660 diagnoses, -6130 to -5200; -15·2%, -16·3 to -14·1). By contrast, axial spondyloarthritis diagnoses increased above pre-pandemic levels (2040 diagnoses, 1670 to 2410; 8·9%, 7·1 to 10·7), with diagnosis rates in women exceeding those in men from 2023 onwards. Early diagnostic deficits in connective tissue diseases were followed by compensatory increases during the pandemic recovery period. INTERPRETATION: Persistent reductions in diagnoses remain evident for psoriatic arthritis, rheumatoid arthritis, and giant cell arteritis 5 years after the onset of the pandemic; contrasting a post-pandemic increase in axial spondyloarthritis diagnoses, particularly in women. Data-driven disease surveillance could be used to identify drivers of these changes and address the long-term impact of delayed diagnosis. FUNDING: None.
引用
- Russell MD, Schaffer A, Yang Z, et al. Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY. Lancet Rheumatol. 2026. PMID: 42379213. doi:10.1016/S2665-9913(26)00142-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。